BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with Is BPC 157 Banned? Oral vs. Injectable Forms Explained FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner